Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02239913Phase 1Completed
Phase 1, randomised, double-blind trial of topiramate in cocaine use disorder (CUD), sponsored by University of Kentucky. Primary endpoint: Reinforcing Effects at 5 weeks. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02239913.